Product Information
ADMELOG 100 UNIT/ML VIAL is a brand product labeled by Sanofi-Aventis U.S. LLC, priced at $12.5612 per ML under NDC 00024592605. Its NADAC has been published 129 times since Apr 17, 2024.
Strength
100 U/mL
Manufacturer
Sanofi-Aventis U.S. LLCNDC
00024592605
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
INSULIN LISPROApproval Type
Biologic (BLA)
FDA Application
BLA209196On Market Since
10/19/2018
Pharmacological Classes
Price Statistics
The NADAC for ADMELOG 100 UNIT/ML VIAL has been published 129 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.5612 per ML |
|---|---|
| All-time high | $12.6123 (Jul 16, 2025) |
| All-time low | $12.5205 (Jun 19, 2024) |
| 52-week high | $12.6042 |
| 52-week low | $12.5227 |
| Median price | $12.5546 |
| Average price | $12.5598 |
| Largest weekly change | -0.4% (May 20, 2026) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 25% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sanofi-Aventis U.S. LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
insulin lispro market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Insulin Analog class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ADMELOG 100 UNIT/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for ADMELOG 100 UNIT/ML VIAL, manufactured by Sanofi-Aventis U.S. LLC, is $12.5612 per ML (NDC 00024592605), effective Sep 30, 2026.
How has the price of ADMELOG 100 UNIT/ML VIAL changed over time?
Over the history we have for it, the NADAC for ADMELOG 100 UNIT/ML VIAL has held within roughly two percent of its current level. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for ADMELOG 100 UNIT/ML VIAL?
Since Apr 17, 2024, the NADAC for ADMELOG 100 UNIT/ML VIAL has ranged from a low of $12.5205 (Jun 19, 2024) to a high of $12.6123 (Jul 16, 2025), with a median of $12.5546 per ML.
Are there cheaper alternatives to ADMELOG 100 UNIT/ML VIAL?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ADMELOG 100 UNIT/ML VIAL, is $9.3938 per ML — about 25% below ADMELOG 100 UNIT/ML VIAL.
Who manufactures ADMELOG 100 UNIT/ML VIAL?
ADMELOG 100 UNIT/ML VIAL (NDC 00024592605) is labeled by Sanofi-Aventis U.S. LLC, and CMS classifies it as a brand product.